Janus Capital Management LLC reduced its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 53.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,705 shares of the real estate investment trust’s stock after selling 8,900 shares during the period. Janus Capital Management LLC’s holdings in Omega Healthcare Investors were worth $254,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Tompkins Financial Corp purchased a new stake in shares of Omega Healthcare Investors during the first quarter worth approximately $165,000. South Texas Money Management Ltd. bought a new position in shares of Omega Healthcare Investors during the first quarter valued at about $207,000. Lodestar Investment Counsel LLC IL bought a new position in shares of Omega Healthcare Investors during the first quarter valued at about $209,000. Wesbanco Bank Inc. bought a new position in shares of Omega Healthcare Investors during the first quarter valued at about $211,000. Finally, Arete Wealth Advisors LLC bought a new position in shares of Omega Healthcare Investors during the first quarter valued at about $216,000. Hedge funds and other institutional investors own 74.57% of the company’s stock.

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) traded down 2.55% on Friday, reaching $30.97. The company had a trading volume of 2,653,015 shares. The firm has a market capitalization of $6.11 billion, a price-to-earnings ratio of 16.34 and a beta of 0.50. Omega Healthcare Investors, Inc. has a 1-year low of $28.11 and a 1-year high of $38.09. The firm has a 50-day moving average price of $32.12 and a 200 day moving average price of $32.51.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.49 by $0.16. The company had revenue of $194 million during the quarter, compared to analyst estimates of $194.59 million. Omega Healthcare Investors had a net margin of 40.20% and a return on equity of 8.88%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.87 EPS. Equities research analysts predict that Omega Healthcare Investors, Inc. will post $1.77 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, August 1st were given a $0.64 dividend. This represents a $2.56 annualized dividend and a yield of 8.27%. The ex-dividend date was Friday, July 28th. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.63. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 135.45%.

COPYRIGHT VIOLATION WARNING: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/19/omega-healthcare-investors-inc-nyseohi-shares-sold-by-janus-capital-management-llc-updated-updated-updated.html.

A number of equities analysts recently weighed in on the company. BidaskClub cut Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $33.00 price objective on shares of Omega Healthcare Investors in a research note on Friday, May 12th. Two equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $34.38.

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 20,000 shares of the firm’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $34.65, for a total value of $693,000.00. Following the completion of the sale, the chief operating officer now owns 90,335 shares in the company, valued at approximately $3,130,107.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 23,000 shares of the firm’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $34.58, for a total transaction of $795,340.00. Following the completion of the sale, the chief financial officer now owns 68,978 shares of the company’s stock, valued at approximately $2,385,259.24. The disclosure for this sale can be found here. Company insiders own 4.54% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Stock Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related stocks with our FREE daily email newsletter.